<DOC>
	<DOCNO>NCT02619786</DOCNO>
	<brief_summary>The purpose study determine whether inhaled colistin effective treatment ventilator associate tracheobronchitis due gram negative organism susceptible colistin .</brief_summary>
	<brief_title>Therapy Ventilator-associated Tracheobronchitis Caused Gram Negative Bacteria With Nebulized Colistin</brief_title>
	<detailed_description>Patients diagnose ventilator-associated tracheobronchitis due gram negative organism include study.The patient receive colistin inhalation 75 mg every 12 hour least 5 day . The primary objective evaluate clinical outcome inhale colistin . The secondary objective microbiological clearance toxicity inhale colistin . The sample size estimate 62 patient .</detailed_description>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>Clinical diagnosis ventilatorassociated tracheobronchitis cause gram negative organism . Expected survive 48 hour enrollment . Received intravenous colistin 48 hour prior enrollment . Pregnancy Lactation Allergy colistin Serum creatinine &gt; 4 mg/dl GFR decrease 75 % baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>